Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oxford Immunotec Global PLC (NASDAQ:OXFD)

16.56
Delayed Data
As of 4:00pm ET
 +0.60 / +3.76%
Today’s Change
11.79
Today|||52-Week Range
19.51
+10.77%
Year-to-Date

Today’s Trading

Previous close15.96
Today’s open15.95
Day’s range15.89 - 16.60
Volume207,268
Average volume (3 months)96,572
Market cap$407.2M
Dividend yield--
Data as of 4:00pm ET, 09/25/2017

Growth & Valuation

Earnings growth (last year)+10.71%
Earnings growth (this year)-58.23%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.11%
P/E ratio--
Price/Sales3.88
Price/Book4.95

Competitors

 Today’s
change
Today’s
% change
CLDXCelldex Therapeutics...+0.34+12.78%
VCYTVeracyte Inc+0.01+0.12%
VIVOMeridian Bioscience ...0.000.00%
CALACalithera Bioscience...+0.05+0.31%
Data as of 4:00pm ET, 09/25/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$86.1M
Annual profit (last year)-$22.3M
Net profit margin-25.96%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Executive Director
Peter James Wrighton-Smith
Chief Operating Officer
Stefan C. Linn
Corporate headquarters
Abingdon, Oxfordshire

Forecasts